Cite
MLA Citation
Remo Panaccione et al.. “Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials.” Journal of Crohn's and colitis, vol. 12, n.d., pp. 930–938. http://access.bl.uk/ark:/81055/vdc_100095513043.0x00000d